Cargando…
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone progressive change, with variants conferring advantage rapidly becoming dominant lineages, e.g., B.1.617. With apparent increased transmissibility, variant B.1.617.2 has contributed to the current wave of infection ravaging t...
Ejemplares similares
-
Antibody evasion by the P.1 strain of SARS-CoV-2
por: Dejnirattisai, Wanwisa, et al.
Publicado: (2021) -
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
por: Zhou, Daming, et al.
Publicado: (2021) -
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
por: Supasa, Piyada, et al.
Publicado: (2021) -
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022) -
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants
por: Liu, Chang, et al.
Publicado: (2022)